NCT00251446View on ClinicalTrials.gov

A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

Vinflunine

320 mg/m2 as a 20-minute IV infusion

Trial Locations (1)

77042

Veeda Oncology, Houston

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Veeda Oncology

OTHER